Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mark Cuban Cost Plus Drug Company, originally founded as Osh's Affordable Pharmaceuticals, is a public benefit corporation dedicated to providing low-cost generic medications through a transparent pricing model. The company operates by bypassing traditional pharmacy benefit managers and wholesalers, offering drugs at a fixed 15% markup over the actual manufacturer cost, plus flat fees for pharmacy labor and shipping. Headquartered in Dallas, Texas, the firm has expanded its operations to include a state-of-the-art manufacturing facility designed to produce sterile injectables and other high-demand medications. By providing clear, cost-based pricing, the company aims to disrupt the pharmaceutical supply chain and significantly reduce the financial burden on patients. Its catalog includes hundreds of generic drugs covering a wide range of therapeutic areas, from oncology to cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osh's Affordable Pharmaceuticals.